Soluble RARRES1 induces podocyte apoptosis to promote glomerular disease progression

Anqun Chen(Zhongshan Hospital of Xiamen University), John Cijiang He(James J. Peters VA Medical Center), Quan Hong(Chinese PLA General Hospital), Jia Fu(Harbin Medical University), Chengguo Wei(Icahn School of Medicine at Mount Sinai), Matthias Kretzler(University of Michigan), Zhengzhe Li(Gannan Medical University), Wenjun Ju(Xuzhou Medical College), Bichen Liu(Chongqing Medical University), Andrew Wang(Icahn School of Medicine at Mount Sinai), Feng Ye(Yangtze University), Kyung Lee(Icahn School of Medicine at Mount Sinai), Li Yu(Zhongshan Hospital of Xiamen University), Tianjun Guan(Zhongshan Hospital of Xiamen University), Han Lai(Icahn School of Medicine at Mount Sinai), Fang Zhong(Icahn School of Medicine at Mount Sinai)
Journal of Clinical Investigation
July 7, 2020
10.1172/jci140155
Cited by 88

Related Papers

Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
|The Lancet|2017|923
The immune cell landscape in kidneys of patients with lupus nephritis
|Nature Immunology|2019|840
Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference
|Kidney International|2020|708
Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach
|Kidney International|2013|350
Enhanced Expression of Janus Kinase–Signal Transducer and Activator of Transcription Pathway Members in Human Diabetic Nephropathy
|Diabetes|2008|315